T2D@ZJU: A knowledgebase integrating heterogeneous connections associated with type 2 diabetes mellitus

Database

Volumn 2013, Issue , 2013, Pages

  Yang, Zhenzhong ^a   Yang, Jihong ^a   Liu, Wei ^a   Wu, Leihong ^a   Xing, Li ^a   Wang, Yi ^a   Fan, Xiaohui ^a   Cheng, Yiyu ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTOME;

ARTICLE; COMPUTER GRAPHICS; COMPUTER INTERFACE; DATA BASE; DATA MINING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTERNET; KNOWLEDGE BASE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN PROTEIN INTERACTION;

COMPUTER GRAPHICS; DATA MINING; DATABASES AS TOPIC; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; HMGA PROTEINS; HUMANS; INTERNET; KNOWLEDGE BASES; PROTEIN INTERACTION MAPS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTOME; USER-COMPUTER INTERFACE;

EID: 84885918778     PISSN: 17580463     EISSN: None     Source Type: Journal    
DOI: 10.1093/database/bat052     Document Type: Article

References (32)

1. Whiting,D.R., Guariguata,L., Weil,C. et al. (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract., 94, 311-321.
2. Chang,K.-H., Chuang,T.-J., Lyu,R.-K. et al. (2012) Identification of gene networks and pathways associated with Guillain-Barre syndrome. PloS One, 7, 80-89.
3. Muoio,D.M. and Newgard,C.B. (2008) Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol., 9, 193-205.
4. Ashcroft,F.M. and Rorsman,P. (2012) Diabetes mellitus and the beta cell: the Last ten years. Cell, 148, 1160-1171.
5. Liechti,R., Csardi,G., Bergmann,S. et al. (2010) EuroDia: a beta-cell gene expression resource. Database, 2010, baq024.
6. Agrawal,S., Dimitrova,N., Nathan,P. et al. (2008) T2D-Db: an integrated platform to study the molecular basis of Type 2 diabetes. BMC Genomics, 9, 320.
7. Lim,J.E., Hong,K.-W., Jin,H.-S. et al. (2010) Type 2 diabetes genetic association database manually curated for the study design and odds ratio. BMC Med. Inform. Decis. Mak, 10, 76.
8. Kanehisa,M., Goto,S., Furumichi,M. et al. (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res., 38, D355-D360.
9. Matthews,L., Gopinath,G., Gillespie,M. et al. (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res., 37, D619-D622.
10. Mi,H., Dong,Q., Muruganujan,A. et al. (2010) PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res., 38, D204-D210.
11. Knox,C., Law,V., Jewison,T. et al. (2011) DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs. Nucleic Acids Res., 39, D1035-D1041.
12. Razick,S., Magklaras,G. and Donaldson,I. (2008) iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinformatics, 9, 405.
13. Hur,J., Schuyler,A.D., States,D.J. et al. (2009) SciMiner: web-based literature mining tool for target identification and functional enrichment analysis. Bioinformatics, 25, 838-840.
14. Lopes,C.T., Franz,M., Kazi,F. et al. (2010) Cytoscape Web: an interactive web-based network browser. Bioinformatics, 26, 2347-2348.
15. Yang,Z.G., Hulver,M., McMillan,R.P. et al. (2012) Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One, 7, e47493.
16. Gu,H.L., Liu,L., Ma,S. et al. (2009) Inhibition of SOCS-3 in adipocytes of rats with diet-induced obesity increases leptin-mediated fatty acid oxidation. Endocrine, 36, 546-554.
17. Reed,A.S., Unger,E.K., Olofsson,L.E. et al. (2010) Functional role of suppressor of cytokine signaling 3 upregulation in hypothalamic leptin resistance and long-term energy homeostasis. Diabetes, 59, 894-906.
18. Emanuelli,B., Peraldi,P., Filloux,C. et al. (2001) SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J. Biol. Chem., 276, 47944-47949.
19. Shi,H., Cave,B., Inouye,K. et al. (2006) Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes, 55, 699-707.
20. Sachithanandan,N., Fam,B.C., Fynch,S. et al. (2010) Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. Hepatology, 52, 1632-1642.
21. Yaspelkis,B.B., Kvasha,I.A. and Figueroa,T.Y. (2009) High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKK alpha/beta phosphorylation and decreases PI-3 kinase activity in muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol., 296, R1709-R1715.
22. Bjorbaek,C., Lavery,H.J., Bates,S.H. et al. (2000) SOCS3 mediates feedback inhibition of the leptin receptor via Tyr(985). J. Biol. Chem., 275, 40649-40657.
23. Babon,J.J., Kershaw,N.J., Murphy,J.M. et al. (2012) Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. Immunity, 36, 239-250.
24. Jorgensen,S.B., O'Neill,H.M., Sylow,L. et al. (2013) Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes, 62, 56-64.
25. Narayana,Y., Bansal,K., Sinha,A.Y. et al. (2009) SOCS3 expression induced by PIM2 requires PKC and PI3K signaling. Mol. Immunol., 46, 2947-2954.
26. Fleischman,A., Shoelson,S.E., Bernier,R. et al. (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care, 31, 289-294.
27. Hundal,R.S., Petersen,K.F., Mayerson,A.B. et al. (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest., 109, 1321-1326.
28. Yuan,M.S., Konstantopoulos,N., Lee,J.S. et al. (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK beta. Science, 293, 1673-1677.
29. Garg,A. (2011) HMGA1, a novel locus for type 2 diabetes mellitus. JAMA, 305, 938-939.
30. Liu,L., Ding,H., Wang,H.R. et al. (2012) Polymorphism of HMGA1 is associated with increased risk of type 2 diabetes among Chinese individuals. Diabetologia, 55, 1685-1688.
31. van Tienen,F., Praet,S., de Feyter,H. et al. (2012) Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. J. Clin. Endocrinol. Metab., 97, 3261-3269.
32. Schrauwen,P. and Hesselink,M.K.C. (2008) Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus? Diabetologia, 51, 1694-1697.